These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9387327)

  • 1. [Clinical significance of c-erbB2 oncoprotein expression in stomach carcinoma].
    Gong Z; Luo E; Lu Q
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):299-301. PubMed ID: 9387327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical study on the expression of c-erbB2 oncoprotein in breast tumors].
    Zhang Z; Xu G; Liu S
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):287-9. PubMed ID: 11038761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of HER-2/neu expression with prognosis of gastric cancer].
    Chen B; Luo RC; Cui F; Qian XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):344-7. PubMed ID: 16546744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-erbB-2 expression is predictive for lymphatic spread of clinical gastric carcinoma.
    Orita H; Maehara Y; Emi Y; Kakeji Y; Baba H; Korenaga D; Sugimachi K
    Hepatogastroenterology; 1997; 44(13):294-8. PubMed ID: 9058162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of c-erbB2 protein and its relation to prognosis in 284 primary breast cancer patients].
    Yang LF; Song ST; Li XB; Jiang ZF; Liu XQ; Ma WN; Jiao XP; Guo SQ
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):294-7. PubMed ID: 16875632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of c-erbB2 expression in breast cancer.
    Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
    J Surg Oncol; 2002 Apr; 79(4):216-23. PubMed ID: 11920778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of c-erbB-2 and PCNA expression in adenocarcinoma of uterine cervix].
    Huang Y; Cai S; Yu S
    Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):150-2. PubMed ID: 10743084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and clinical significance of p53 and c-erbB2 in geriatric women with cervical carcinoma].
    Huang YW; Li MD; Wu QL; Liu FY
    Ai Zheng; 2002 Mar; 21(3):297-300. PubMed ID: 12451999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
    Liu L; Yang K
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):101-4. PubMed ID: 11263193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma.
    Inada T; Kikuyama S; Ichikawa A; Igarashi S; Ogata Y
    Anticancer Res; 1998; 18(3B):2003-10. PubMed ID: 9677457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship of oncogene C-erbB2 expression to ER, PR and PS2 in breast cancer and its prognostic significance].
    Yang JQ; Chen L; Xing TY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):334-6, 357. PubMed ID: 15181828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of osteopontin expression in human gastric carcinoma.
    Higashiyama M; Ito T; Tanaka E; Shimada Y
    Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and significance of cell cycle regulators in gastric carcinoma].
    Wu JF; Shao JC; Wang DB; Qin R; Zhang H
    Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
    Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of nm23 gene expression in gastric cancer.
    Mönig SP; Nolden B; Lübke T; Pohl A; Grass G; Schneider PM; Dienes HP; Hölscher AH; Baldus SE
    Anticancer Res; 2007; 27(4C):3029-33. PubMed ID: 17695492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.
    Ougolkov A; Mai M; Takahashi Y; Omote K; Bilim V; Shimizu A; Minamoto T
    J Exp Clin Cancer Res; 2000 Sep; 19(3):349-55. PubMed ID: 11144528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric carcinoma: expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72 in different histological types.
    Peláez Buján Mdel C; Ruibal Morell A; Aza González J
    Rev Esp Enferm Dig; 1999 Dec; 91(12):826-37. PubMed ID: 10619912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
    Matsubara J; Yamada Y; Hirashima Y; Takahari D; Okita NT; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
    Clin Cancer Res; 2008 May; 14(10):3022-9. PubMed ID: 18483367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.